| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Preclinical and Clinical Pharmacology, Human Anatomy and Histology, Section of Histology, University of Florence, and Prosperius Institute, Florence, Italy
Address all correspondence and requests for reprints to: Prof. Tatiana Bani Sacchi, Dipartimento di Anatomia Umana e Istologia, Sezione di Istologia, V.le G.Pieraccini, 6, I-50139 Firenze, Italy. E-mail: histology{at}cesit1.unifi.it
Relaxin was previously shown to cause coronary vasodilation and to inhibit mast cell activation through a stimulation of endogenous nitric oxide production. This suggests that relaxin may have beneficial effects on ischemia-reperfusion-induced myocardial injury, which is triggered by endothelial damage and impaired nitric oxide generation. In this study, we tested the effect of relaxin on isolated and perfused guinea pig hearts subjected to ischemia and reperfusion. Ischemia was induced by ligature of the left anterior descending coronary artery; removal of the ligature induced reperfusion. Relaxin, at the concentration of 30 ng/ml of perfusion fluid, causes: a significant increase in coronary flow and in nitric oxide generation; a significant decrease in malonyldialdehyde production and in calcium overload, both markers of myocardial injury; an inhibition of mast cell granule exocytosis and histamine release, which are known to contribute to myocardial damage; a reduction of ultrastructural abnormalities of myocardial cells; an improvement of heart contractility. The beneficial effects of relaxin were blunted by the NO synthase inhibitor L-NMMA. The current study provides first experimental evidence that relaxin has a powerful protective effect on the heart undergoing ischemia and reperfusion acting through a nitric oxide-driven mechanism.
This article has been cited by other articles:
![]() |
S. Hombach-Klonisch, J. Bialek, B. Trojanowicz, E. Weber, H.-J. Holzhausen, J. D. Silvertown, A. J. Summerlee, H. Dralle, C. Hoang-Vu, and T. Klonisch Relaxin Enhances the Oncogenic Potential of Human Thyroid Carcinoma Cells Am. J. Pathol., August 1, 2006; 169(2): 617 - 632. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Bathgate, R. Ivell, B. M. Sanborn, O. D. Sherwood, and R. J. Summers International Union of Pharmacology LVII: Recommendations for the Nomenclature of Receptors for Relaxin Family Peptides. Pharmacol. Rev., March 1, 2006; 58(1): 7 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Figueiredo, A. L. Mui, C. C. Nelson, and M. E. Cox Relaxin Stimulates Leukocyte Adhesion and Migration through a Relaxin Receptor LGR7-dependent Mechanism J. Biol. Chem., February 10, 2006; 281(6): 3030 - 3039. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. O. Debrah, K. P. Conrad, A. Jeyabalan, L. A. Danielson, and S. G. Shroff Relaxin Increases Cardiac Output and Reduces Systemic Arterial Load in Hypertensive Rats Hypertension, October 1, 2005; 46(4): 745 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Formigli, F. Francini, A. Tani, R. Squecco, D. Nosi, L. Polidori, S. Nistri, L. Chiappini, V. Cesati, A. Pacini, et al. Morphofunctional integration between skeletal myoblasts and adult cardiomyocytes in coculture is favored by direct cell-cell contacts and relaxin treatment Am J Physiol Cell Physiol, April 1, 2005; 288(4): C795 - C804. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. P. Conrad and J. Novak Emerging role of relaxin in renal and cardiovascular function Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2004; 287(2): R250 - R261. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Quattrone, L. Chiappini, G. Scapagnini, B. Bigazzi, and D. Bani Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture Mol. Hum. Reprod., May 1, 2004; 10(5): 325 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Masini, A. Vannacci, C. Marzocca, S. Pierpaoli, L. Giannini, O. Fantappie, R. Mazzanti, and P. F. Mannaioni Heme Oxygenase-1 and the Ischemia-Reperfusion Injury in the Rat Heart Experimental Biology and Medicine, May 1, 2003; 228(5): 546 - 549. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bani, M. Caterina Baccari, S. Quattrone, S. Nistri, F. Calamai, M. Bigazzi, and T. Bani Sacchi Relaxin Depresses Small Bowel Motility Through a Nitric Oxide-Mediated Mechanism. Studies in Mice Biol Reprod, March 1, 2002; 66(3): 778 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. D. Sherwood, L. M. Olson, S. Zhao, and H. R. Little Inhibition of Nitric Oxide Synthase Activity Diminishes the Acute Effects of Relaxin on Growth, But Not Softening, of the Cervix in the Rat Endocrinology, July 1, 2000; 141(7): 2458 - 2464. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Shi, S.-Q. Shi, G. R. Saade, K. Chwalisz, and R. E. Garfield Studies of cervical ripening in pregnant rats: effects of various treatments Mol. Hum. Reprod., April 1, 2000; 6(4): 382 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Bani, M. C. Baccari, S. Nistri, F. Calamai, M. Bigazzi, and T. B. Sacchi Relaxin Up-Regulates the Nitric Oxide Biosynthetic Pathway in the Mouse Uterus: Involvement in the Inhibition of Myometrial Contractility Endocrinology, October 1, 1999; 140(10): 4434 - 4441. [Abstract] [Full Text] |
||||
![]() |
D. Bani, P. Failli, M. G. Bello, C. Thiemermann, T. B. Sacchi, M. Bigazzi, and E. Masini Relaxin Activates the L-Arginine–Nitric Oxide Pathway in Vascular Smooth Muscle Cells in Culture Hypertension, June 1, 1998; 31(6): 1240 - 1247. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |